Trending NewsTrending NewsNYSE:QGEN QIAGEN (QGEN) Stock Price, News & Analysis $46.53 +0.39 (+0.85%) Closing price 03:59 PM EasternExtended Trading$46.77 +0.24 (+0.51%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About QIAGEN Stock (NYSE:QGEN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get QIAGEN alerts:Sign Up Key Stats Today's Range$46.08▼$46.6350-Day Range$46.07▼$51.8052-Week Range$37.63▼$51.88Volume1.97 million shsAverage Volume1.49 million shsMarket Capitalization$10.34 billionP/E Ratio27.49Dividend Yield0.54%Price Target$49.69Consensus RatingHold Company Overview QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands. Read More QIAGEN Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreQGEN MarketRank™: QIAGEN scored higher than 79% of companies evaluated by MarketBeat, and ranked 216th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.1 / 5Analyst RatingHold Consensus RatingQIAGEN has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 3 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageQIAGEN has only been the subject of 4 research reports in the past 90 days.Read more about QIAGEN's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.85% Earnings GrowthEarnings for QIAGEN are expected to grow by 8.85% in the coming year, from $2.26 to $2.46 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of QIAGEN is 27.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 98.68.Price to Earnings Ratio vs. SectorThe P/E ratio of QIAGEN is 27.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 59.66.Price to Earnings Growth RatioQIAGEN has a PEG Ratio of 2.42. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQIAGEN has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about QIAGEN's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.07% of the float of QIAGEN has been sold short.Short Interest Ratio / Days to CoverQIAGEN has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in QIAGEN has recently increased by 4.76%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldQIAGEN has a dividend yield of 0.54%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthQIAGEN does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of QIAGEN is 14.79%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, QIAGEN will have a dividend payout ratio of 10.16% next year. This indicates that QIAGEN will be able to sustain or increase its dividend.Read more about QIAGEN's dividend. Sustainability and ESG4.5 / 5Environmental Score-0.83 Percentage of Shares Shorted3.07% of the float of QIAGEN has been sold short.Short Interest Ratio / Days to CoverQIAGEN has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in QIAGEN has recently increased by 4.76%, indicating that investor sentiment is decreasing. News and Social Media3.5 / 5News Sentiment1.22 News SentimentQIAGEN has a news sentiment score of 1.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 24 news articles for QIAGEN this week, compared to 8 articles on an average week.Search Interest1 people have searched for QGEN on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, QIAGEN insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.00% of the stock of QIAGEN is held by insiders.Percentage Held by Institutions70.00% of the stock of QIAGEN is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about QIAGEN's insider trading history. Receive QGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QIAGEN and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QGEN Stock News HeadlinesQIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible BondsAugust 28 at 5:08 PM | businesswire.comQIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible BondsAugust 28 at 12:11 PM | businesswire.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.August 29 at 2:00 AM | Brownstone Research (Ad)QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible BondsAugust 28 at 2:05 AM | businesswire.comQiagen Receives Notification of BlackRock’s Significant StakeAugust 26 at 12:08 AM | msn.comQiagen Announces Major BlackRock ShareholdingAugust 26 at 12:08 AM | msn.comBrokerages Set QIAGEN N.V. (NYSE:QGEN) PT at $49.69August 25, 2025 | americanbankingnews.comQiagen: Diagnostics Vs. Life Sciences Pair Trade AnalysisAugust 21, 2025 | seekingalpha.comSee More Headlines QGEN Stock Analysis - Frequently Asked Questions How have QGEN shares performed this year? QIAGEN's stock was trading at $43.2931 at the start of the year. Since then, QGEN stock has increased by 7.5% and is now trading at $46.5340. How were QIAGEN's earnings last quarter? QIAGEN N.V. (NYSE:QGEN) released its earnings results on Tuesday, August, 5th. The company reported $0.60 EPS for the quarter, hitting analysts' consensus estimates of $0.60. The business's revenue for the quarter was up 7.7% compared to the same quarter last year. Read the conference call transcript. When did QIAGEN's stock split? QIAGEN's stock split before market open on Wednesday, January 29th 2025.The 36-35 split was announced on Wednesday, January 22nd 2025. The newly issued shares were distributed to shareholders after the market closes on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split. Who are QIAGEN's major shareholders? Top institutional shareholders of QIAGEN include Massachusetts Financial Services Co. MA (11.03%), Groupama Asset Managment (6.75%), Amundi (1.85%) and Norges Bank (1.48%). How do I buy shares of QIAGEN? Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of QIAGEN own? Based on aggregate information from My MarketBeat watchlists, some other companies that QIAGEN investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and PayPal (PYPL). Company Calendar Record date for 7/10 Dividend7/02/2025Ex-Dividend for 7/10 Dividend7/02/2025Dividend Payable7/10/2025Last Earnings8/05/2025Today8/29/2025Next Earnings (Estimated)11/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNYSE:QGEN CIK1015820 Webwww.qiagen.com Phone(177) 355-6600Fax31-77-355-6658Employees5,765Year FoundedN/APrice Target and Rating Average Price Target for Qiagen$49.69 High Price Target$55.00 Low Price Target$43.00 Potential Upside/Downside+6.8%Consensus RatingHold Rating Score (0-4)2.27 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$1.69 Trailing P/E Ratio27.49 Forward P/E Ratio20.59 P/E Growth2.52Net Income$83.59 million Net Margins18.30% Pretax Margin23.95% Return on Equity14.77% Return on Assets8.87% Debt Debt-to-Equity Ratio0.25 Current Ratio1.61 Quick Ratio1.35 Sales & Book Value Annual Sales$2.04 billion Price / Sales5.07 Cash Flow$3.11 per share Price / Cash Flow14.97 Book Value$15.77 per share Price / Book2.95Miscellaneous Outstanding Shares222,291,000Free Float202,285,000Market Cap$10.34 billion OptionableOptionable Beta0.64 Social Links 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:QGEN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QIAGEN N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share QIAGEN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.